Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary
Open Access
- 1 September 2016
- journal article
- editorial
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 3, 37-40
Abstract
The fifth most common cancer worldwide is hepatocellular carcinoma (HCC), while being the third leading cause of global cancer-related deaths. Although HCC incidence is less frequent in North America, it is a common malignancy in Asia and Africa associated with a high rate of mortality and morbidity due to ineffective therapies against cancer growth, invasion, and metastasis. It is well established that serum alpha-fetoprotein (AFP) is the “gold standard” biomarker for liver cancer; however, less known are the biological activities of AFP regarding carcinogenesis, growth, proliferation, and metastasis. Clinicians are well aware that increasing AFP serum levels parallel disease progression of HCC patients, but many are less knowledgeable in the lethal growth-promoting properties of AFP as an autocrine stimulator of hepatoma cell proliferation. This commentary addresses the mortality and morbidity concerning AFP in the genesis, growth, progression, and spread of HCC and emphasizes the perilous consequences of AFP-supported growth in human liver cancer even after liver resection and transplantation. Thus, AFP is not just a biomarker for HCC but also an ardent promoter of liver cancer growth and progression.Keywords
This publication has 29 references indexed in Scilit:
- Alpha-fetoprotein acts as a novel signal molecule and mediates transcription of Fn14 in human hepatocellular carcinomaJournal of Hepatology, 2012
- Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein levelSurgery Today, 2011
- Downregulation of alpha-fetoprotein expression by LHX4: a critical role in hepatocarcinogenesisCarcinogenesis, 2011
- Impact of intracellular alpha fetoprotein on retinoic acid receptors‐mediated expression of GADD153 in human hepatoma cell linesInternational Journal of Cancer, 2011
- Alpha‐fetoprotein: A new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell linesInternational Journal of Cancer, 2010
- Alpha fetoprotein is a novel protein‐binding partner for caspase‐3 and blocks the apoptotic signaling pathway in human hepatoma cellsInternational Journal of Cancer, 2009
- Clinical significance of α‐fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2008
- Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycleClinica Chimica Acta, 2008
- α-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligandCancer Letters, 2007
- Biological role of α-fetoprotein in cancer: prospects for anticancer therapyExpert Review of Anticancer Therapy, 2002